LONDON – (BUSINESS BUSINESS) – Market sellers are increasingly focusing on adopting a more targeted approach such as anabolic medication to treat the disease effectively. Anabolic medication improves bone quality and increases its mass, contributes to the formation of new bone, and reduces broken incidence. The approval of such drugs and the presence of a favorable drugs pipeline will therefore boost the growth of the osteoporosis drug market during the forecast period. In addition, this industry research report provides competitive analysis of the market available by geography (North America, Europe, Asia, and ROW), and product (anti-reflective drugs and anabolic drugs).
This press release contains multimedia. See full release here: https://www.businesswire.com/news/home/20190731005453/en/
Technavio announced its latest market research report titled global osteoporosis drugs market 2019-2023. (Graphic: Business Wire)
Competitor seller landscape
The global osteoporosis drug market is very competitive with major sellers such as Amgen Inc., Eli Lilly and Company, Novartis AG, Pfizer Inc., and Radius Health, Inc., competing on the basis of price, quality, and market presence.
“The increasing need to provide a new administrative route for patients with effective drug delivery has led to the emergence of a transdermal drug delivery system. These systems ensure that drugs are available on the targeted site to take long action. Therefore, the development of the transdermal drug delivery system will boost the growth of the osteoporosis drug market during the forecast period, ”says senior analyst at Technavio..
Top five sellers osteoporosis drug market
Amgen Inc. engaged in developing products in oncology / hematology, cardiovascular, neuroscience, inflammation, bone health, and biosciences. Prolia, a human monoclonal antibody used for the treatment of osteoporosis, and MOBILITY, which reduces the risk of fractures and increases the density of bone minerals among men and women who have osteoporosis with osteoporosis are among the company's main offers.
Eli Lilly and Company
Eli Lilly and the Company own and work under two items: human pharmaceutical products, and animal health products. The company's main products in the Osteoporosis drug market are FORTEO and Evista.
Novartis AG develops innovative medicines under two business units, namely Novartis Pharmaceuticals and Novartis Oncology. Novartis Pharmaceuticals provides patented treatments in the areas of ophthalmology, immunology, dermatology, neuroscience, respiratory, and cardiopathy. Under the category of osteoporosis drugs, the company offers ZOMETA, Reclast, and Miacalcin available.
Pfizer Inc. operates. two items, namely innovative health and essential health. The company offers two drugs to treat osteoporosis, including Viviant, an optional estrogen receptacle used to treat osteoporosis, and PREMARIN, which is used to treat osteoporosis in women.
Radius Health, Inc.
Radius Health, Inc. research and development of drug therapies to treat osteoporosis. The company offers TYMLOS, which is a hormonal protein parathyroid output drugs used to treat osteoporosis.
Looking for more information on this market? Ask for a free sample sample
Technavio sample reports are free and contain elements of the report including market size and forecast, drivers, challenges, trends, and more.
Browse Related Reports: t
- Global Orthopedic Implant Market 2019-2023 – The study identifies market research B. Braun Melsungen, Johnson & Johnson, Smith & Nephew, Stryker, Wright Medical Group, and Zimmer Biomet, as the main players in the global orthopedic implant market.
- 3D Orthopedic 3D Printing Market 2019-2023 – The study identifies market research of 3D Systems, EnvisionTEC, EOS, ELECTRICAL GENERAL, Materialize, and Stratasys Ltd., as the main players in the 3D orthopedic printing device market.
Technavio is a leading global technology research and advice company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialist analyzes, the Technavio report library has over 10,000 reports and counts, covering 800 technologies, covering 50 countries. Its client base includes enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base depends on the comprehensive coverage of Technavio, extensive research, and actionable market insights to identify opportunities in existing and potential markets and to assess their competitive positions within market situations. changing.
For more information, please contact our media team at email@example.com.
.Leave a comment